Projects implemented at MMRI PAS funded by Medical Research Agency:
A randomised, blind placebo-controlled, phase 3 study to evaluate the efficacy and safety of cladribine in myasthenia gravis with acetylcholine receptor antibodies.
Project manager: prof. Paweł Grieb MD PhD as a representative of MMRI PAS
Project implemented in consortium: Medical University of Lublin (Leader), Institute of Psychiatry and Neurology in Warsaw, The Łukasiewicz Research Network – prof. I. Mościcki Industrial Chemistry Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London
International collaboration: Great Britain
2019/ABM/01 call, implementation period: 2020 – 2026, project funding: PLN 26 349 901,54
Innovative application of stem cells and neurotrophin-releasing biocompatible polyelectrolyte nanoparticles in the adjuvant therapy of neurodegenerative diseases.
Project manager: Prof. Anna Sarnowska MD PhD as a representative of MMRI PAS
Project implemented in consortium: Pomeranian Medical University (Leader), Medical University of Warsaw, University of Warmia and Mazury in Olsztyn
ABM/2020/1 call, implementation period: 2021 – 2025, project funding: PLN 17 497 978
The application of platelet-rich leukocyte fibrin as angiogenesis stimulator in patients undergoing revascularization as therapy in critical lower limbs ischemia
Project manager: Luiza Stanaszek PhD as a representative of MMRI PAS
Project implemented in consortium: Medical University of Warsaw (Leader) University Clinical Center of the Medical University of Warsaw, Warsaw University of Life Sciences, diCELLa Sp. z.o.o
2020/ABM/01 call, implementation period: 2021 – 2026, project funding: PLN 8 676 067,60
Study to evaluate the efficacy and safety of Polish cladribine in the treatment of patients with secondary progressive multiple sclerosis - a phase 2, randomized, double-blind, placebo-controlled trial
Project manager: prof. Paweł Grieb MD PhD as a respresenative of MMRI PASProject implemented in consortium with:Instytut Psychiatrii i Neurologii(Lider), Military Institute of Aviation Medicine, Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences2021/ABM/02 call, implementation period: 2021– 2027, project funding: PLN 9 704 627,60
